Correlation Between Sunshine Biopharma and Procaps Group
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma Warrant and Procaps Group SA, you can compare the effects of market volatilities on Sunshine Biopharma and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Procaps Group.
Diversification Opportunities for Sunshine Biopharma and Procaps Group
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Sunshine and Procaps is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma Warrant and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma Warrant are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Procaps Group go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Procaps Group
Assuming the 90 days horizon Sunshine Biopharma Warrant is expected to generate 1.77 times more return on investment than Procaps Group. However, Sunshine Biopharma is 1.77 times more volatile than Procaps Group SA. It trades about 0.22 of its potential returns per unit of risk. Procaps Group SA is currently generating about -0.4 per unit of risk. If you would invest 16.00 in Sunshine Biopharma Warrant on November 3, 2024 and sell it today you would earn a total of 8.00 from holding Sunshine Biopharma Warrant or generate 50.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 70.59% |
| Values | Daily Returns |
Sunshine Biopharma Warrant vs. Procaps Group SA
Performance |
| Timeline |
| Sunshine Biopharma |
| Procaps Group SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Sunshine Biopharma and Procaps Group Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Procaps Group
The main advantage of trading using opposite Sunshine Biopharma and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
| Procaps Group vs. Procaps Group SA | Procaps Group vs. Quantum Si incorporated | Procaps Group vs. Jasper Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |